NCT04904458

Brief Summary

The concept of body image can be described as "the intentional content of consciousness comprising perceptions, attitudes and beliefs relating to one's body". Over the years, there has been a growing interest in this topic, highlighting that body image can be distorted in people suffering from pain conditions, especially in the case of chronic pain. One way of modulating the perception of pain through the perception of body image is through the use of interventions based on visual feedback. In this regard, some studies have highlighted the possibility of reducing the perception of pain in healthy and clinical populations with the use of "illusions" of one's own body created through immersive virtual reality. For example, through the use of synchronous visual-tactile multisensory stimulation on one's own face / body and on that of others (fake body), is possible to induce illusions of self-recognition in other fake bodies. In the case of the face, this type of illusion of belonging of other faces is commonly known as the "enfacement illusion", through which is possible to change or modulate the self-representation, with important implications for all those subjects who have distorted body representations, such as patients suffering from chronic pain. The main goal of the present protocol is to evaluate the effects of an experimental treatment based on enfacement illusion on the perception of pain (VAS scale) with respect to a control condition (pleasant virtual environment exposure). The secondary objective is to study any correlations between pain and body image, personal, clinical and psychological intrapersonal variables. One-hundred patients with chronic headache will be randomly assigned to the two conditions: experimental group (based on the "enfacement illusion") and control group (exposed to a pleasant virtual environment). Both conditions include an immersive virtual reality treatment of 3 sessions of 15 minutes each, during one week.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2021

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 27, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

October 13, 2021

Status Verified

May 1, 2021

Enrollment Period

2.9 years

First QC Date

May 5, 2021

Last Update Submit

October 12, 2021

Conditions

Keywords

Virtual realityChronic migrainePainEnfacement illusionNon-pharmacological treatmentsEmotional regulation

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale (VAS)

    To assess the effects on pain perception measured by a 0-100 Visual Analogue Scale (VAS) of a one-week treatment based on "enfacement illusion" compared to a control condition (pleasant virtual environment exposure) in patients with chronic migraine

    Change fromT0 (baseline) toT1 (at the end of the intervention, i.e. after one-week)

Secondary Outcomes (7)

  • Body Image Questionnaire (BIQ)

    Change fromT0 (baseline) toT1 (at the end of the intervention, i.e. after one-week)

  • Positive and Negative Affect Schedule (PANAS)

    Change fromT0 (baseline) toT1 (at the end of the intervention, i.e. after one-week)

  • Body Satisfaction Scale (BSS)

    Change fromT0 (baseline) toT1 (at the end of the intervention, i.e. after one-week)

  • The Hospital Anxiety and Depression Scale (HADS)

    Change fromT0 (baseline) toT1 (at the end of the intervention, i.e. after one-week)

  • The Emotive Regulation Questionnaire (ERQ)

    Change fromT0 (baseline) toT1 (at the end of the intervention, i.e. after one-week)

  • +2 more secondary outcomes

Study Arms (2)

Experimental group

EXPERIMENTAL

The experimental group receives the Enfacement Illusion toward a happy emotional face through a head mounted display.

Other: Experimental group ("enfacement illusion")

Control Group

SHAM COMPARATOR

The control group receives the exposure to a pleasant virtual environment through a head mounted display

Other: Control Group (Pleasant virtual environment exposure)

Interventions

Virtual reality enfacement illusion exposure

Experimental group

Pleasant virtual environment exposure

Control Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThere are studies reporting differences in pain perception between man and women (Wiesenfeld-Hallin, 2005)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Accomplish the clinical characteristics included in the ICHD-III version for chronic migraine.
  • Age between \>18 to 65 year old (only women).
  • Previous history of migraine as primary headache.
  • Pain perception between 20 and 80 on a 0-100 VAS.

You may not qualify if:

  • Dementia, epilepsy, psychosis, mental retardation, pregnant and breastfeeding women.
  • Visual problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Headache Science Center

Pavia, 27100, Italy

RECRUITING

Related Publications (14)

  • Balzarotti, Stefania, Oliver P. John, and James J. Gross. 2010. "An Italian Adaptation of the Emotion Regulation Questionnaire." European Journal of Psychological Assessment. https://doi.org/10.1027/1015-5759/a000009.

    BACKGROUND
  • Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, Venturini M, Morasso G. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer. 1999 May;7(3):121-7. doi: 10.1007/s005200050241.

    PMID: 10335929BACKGROUND
  • Longo MR, Schuur F, Kammers MP, Tsakiris M, Haggard P. What is embodiment? A psychometric approach. Cognition. 2008 Jun;107(3):978-98. doi: 10.1016/j.cognition.2007.12.004. Epub 2008 Feb 11.

    PMID: 18262508BACKGROUND
  • Lotze M, Moseley GL. Role of distorted body image in pain. Curr Rheumatol Rep. 2007 Dec;9(6):488-96. doi: 10.1007/s11926-007-0079-x.

    PMID: 18177603BACKGROUND
  • Matamala-Gomez M, Donegan T, Bottiroli S, Sandrini G, Sanchez-Vives MV, Tassorelli C. Immersive Virtual Reality and Virtual Embodiment for Pain Relief. Front Hum Neurosci. 2019 Aug 21;13:279. doi: 10.3389/fnhum.2019.00279. eCollection 2019.

    PMID: 31551731BACKGROUND
  • Nicolodi M, Sandoval V. P012. Body image role in medication-overuse headache associated with persistent depressive disorder. J Headache Pain. 2015 Dec;16(Suppl 1):A111. doi: 10.1186/1129-2377-16-S1-A111. No abstract available.

    PMID: 28132277BACKGROUND
  • Porciello G, Bufalari I, Minio-Paluello I, Di Pace E, Aglioti SM. The 'Enfacement' illusion: A window on the plasticity of the self. Cortex. 2018 Jul;104:261-275. doi: 10.1016/j.cortex.2018.01.007. Epub 2018 Feb 9.

    PMID: 29478669BACKGROUND
  • Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983 Sep;17(1):45-56. doi: 10.1016/0304-3959(83)90126-4.

    PMID: 6226917BACKGROUND
  • Sforza A, Bufalari I, Haggard P, Aglioti SM. My face in yours: Visuo-tactile facial stimulation influences sense of identity. Soc Neurosci. 2010;5(2):148-62. doi: 10.1080/17470910903205503. Epub 2009 Oct 7.

    PMID: 19813138BACKGROUND
  • Terracciano A, McCrae RR, Costa PT Jr. Factorial and construct validity of the Italian Positive and Negative Affect Schedule (PANAS). Eur J Psychol Assess. 2003;19(2):131-141. doi: 10.1027//1015-5759.19.2.131.

    PMID: 20467578BACKGROUND
  • de Tommaso M, Calabrese R, Vecchio E, De Vito Francesco V, Lancioni G, Livrea P. Effects of affective pictures on pain sensitivity and cortical responses induced by laser stimuli in healthy subjects and migraine patients. Int J Psychophysiol. 2009 Nov;74(2):139-48. doi: 10.1016/j.ijpsycho.2009.08.004. Epub 2009 Aug 25.

    PMID: 19712710BACKGROUND
  • Valentini E, Martini M, Lee M, Aglioti SM, Iannetti G. Seeing facial expressions enhances placebo analgesia. Pain. 2014 Apr;155(4):666-673. doi: 10.1016/j.pain.2013.11.021. Epub 2013 Dec 6.

    PMID: 24315986BACKGROUND
  • Yetkin-Ozden S, Ekizoglu E, Baykan B. Face recognition in patients with migraine. Pain Pract. 2015 Apr;15(4):319-22. doi: 10.1111/papr.12191. Epub 2014 Apr 12.

    PMID: 24725507BACKGROUND
  • Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med. 2005 Sep;2(3):137-45. doi: 10.1016/s1550-8579(05)80042-7.

    PMID: 16290886BACKGROUND

MeSH Terms

Conditions

Migraine DisordersPainEmotional Regulation

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSelf-ControlSocial BehaviorBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Cristina Tassorelli, Prof

    Headache Science Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sara Bottiroli, PhD

CONTACT

Cinzia Fattore, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2021

First Posted

May 27, 2021

Study Start

April 30, 2021

Primary Completion

March 30, 2024

Study Completion

March 30, 2024

Last Updated

October 13, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations